Novo Nordisk A/S (NVO) NYSE

58.20

+1(+1.75%)

Updated at September 17 04:00PM

Currency In USD

Valuation

Market Cap2.76T
Enterprise Value2.85T
P/E Ratio14.79
PEG Ratio2.38
Price/Sales Ratio5.26
Price/Book Ratio9.78
Enterprise/Revenue5.52
Enterprise/EBITDA11.16

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.36
Operating Margin0.46

Management Effectiveness

Return On Assets0.23
Return On Equity0.78

Income Statement

Revenue290.4B
Revenue/Share70.15
Gross Profit245.88B
EBITDA137.38B
Net Income100.99B
Diluted EPS22.63

Balance Sheet

Total Cash18.93B
Total Cash/Share4.26
Total Debt99.27B
Total Debt/Equity0.59
Current Ratio0.78
Book Value Per Share37.79

Price History

52-Week Change-55.74
52-Week High135.2
52-Week Low45.05
Moving Average 50 Days57.7
Moving Average 200 Days73.91

Statistics

Average Volume16.27M
Shares Outstanding4.44B
% Held by Institutions6.69

Dividend And Splits

Trailing Annual Dividend Rate11.65
Trailing Annual Dividend Yield3.15
Payout Ratio0.46
Last Split Factor2:1
Last Split DateSeptember 20, 2023